FORWARD-LOOKING STATEMENTS

WASHINGTON, Jan. 8, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has received…

WILMINGTON, Del., Dec. 29, 2025 /PRNewswire/ — Brand Engagement Network Inc. (Nasdaq: BNAI) (“BEN” or the “Company”), a…

Vigoride‑7 to launch on SpaceX’s Transporter‑16 delivering several innovative payloads to advance capabilities in space SAN JOSE, Calif.,…

NEW YORK, NY / ACCESS Newswire / December 5, 2025 / In every major technological era, a single…

FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of…

Singapore, Singapore–(Newsfile Corp. – November 21, 2025) – Mobile-health Network Solutions (NASDAQ: MNDR) (“MNDR” or the “Company”), a…

Rocket Lab Corporation LONG BEACH, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket…

Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE…

New advancement lays groundwork for quantum-enhanced modeling in carbon capture and molecular dynamics COLLEGE PARK, Md., October 13,…

Rocket Lab Corporation LONG BEACH, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) — Rocket Lab USA, Inc. (Nasdaq: RKLB)…

Breakthrough paves the way for interconnecting quantum computers over vast distances by leveraging existing fiber optic infrastructure COLLEGE…

LOS ANGELES, CA – September 17, 2025 (NEWMEDIAWIRE) – D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or “The Company”),…

Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder